Physician profile
Devy A Setyono
NPI 1962815878
$8,805.09
in general payments reported to CMS, 2019-2025
38 companies · $413 in 2025
The $413 reported for 2025 was less than what a typical Rheumatology provider received nationally (typical 2025 total: $894).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $846 · 2020: $1,275 · 2021: $1,786 · 2022: $1,623 · 2023: $2,218 · 2024: $644 · 2025: $413.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,198 · Education: $76.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,198.30 |
| Education | $76.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $2,060.45 | 2019-2024 | Tavneos, Enbrel, Prolia |
| Abbvie INC. | $1,826.44 | 2019-2024 | Rinvoq, Skyrizi, Humira |
| Janssen Biotech, INC. | $549.68 | 2019-2024 | Tremfya, Simponi Aria |
| E.R. Squibb & Sons, L.L.C. | $454.50 | 2019-2023 | Orencia |
| Glaxosmithkline, LLC. | $397.83 | 2020-2025 | Benlysta |
| Astrazeneca Pharmaceuticals Lp | $347.15 | 2021-2024 | Saphnelo |
| Lilly USA, LLC | $289.19 | 2019-2024 | Taltz, Olumiant |
| Radius Health, INC. | $258.12 | 2019-2023 | Tymlos |
| Aurinia Pharma U.S., INC. | $230.37 | 2021-2024 | Lupkynis |
| Janssen Scientific Affairs, LLC | $214.84 | 2020-2022 | |
| Mallinckrodt Hospital Products INC. | $198.09 | 2020-2023 | Acthar |
| Alexion Pharmaceuticals, INC. | $192.36 | 2019-2023 | Ultomiris, Strensiq |
| Ucb, INC. | $187.26 | 2021-2024 | Cimzia |
| Pfizer INC. | $164.50 | 2019-2022 | |
| Ani Pharmaceuticals, INC. | $158.09 | 2022-2024 | Purified Cortrophin Gel |
Show all 38 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Devy Setyono listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.